By Mill Chart
Last update: Jun 2, 2025
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) was identified as a decent value stock by our screener. The company, a leader in orthopedic medical devices, shows strong profitability and reasonable valuation metrics while maintaining financial health. Here’s why ZBH stands out as a potential opportunity for value investors.
ZBH scores an 8/10 in valuation, indicating it is priced attractively compared to peers and broader market benchmarks:
With a profitability rating of 8/10, ZBH demonstrates strong earnings power:
ZBH holds a 5/10 health rating, with some strengths and minor concerns:
While growth is modest (4/10), there are positive signs:
Our Decent Value Stocks screener lists more stocks with similar characteristics.
For a deeper dive, review the full fundamental report on ZBH.
This is not investment advice. Always conduct your own research before making investment decisions.
92.34
+0.84 (+0.92%)
Find more stocks in the Stock Screener
ZIMMER BIOMET (NYSE:ZBH) is an undervalued medical device stock with strong profitability, a reasonable dividend, and improving growth prospects. A solid pick for value investors.
Zimmer Biomet Holdings (NYSE:ZBH) offers a reliable dividend with strong profitability and reasonable valuation, making it a solid pick for income investors.